CGD Releases Report On Improving Clinical Trials, Regulatory Pathways For Fighting Neglected Diseases

The Center for Global Development (CGD) last week released a new report on global health, the Global Health Technology Coalition’s “Breakthroughs” blog reports. The report — the product of a working group that included representatives from donor groups, philanthropy groups, product development partnerships (PDPs), consulting firms, the pharmaceutical industry, government, researchers, and developing and developed country regulators — is titled, “Safer, Faster, Cheaper: Improving Clinical Trials and Regulatory Pathways to Fight Neglected Disease,” and “outlines a two-pronged approach — establishing regional regulatory pathways for the oversight of clinical trials, and building quality and cost-efficiency into trial planning and design,” according to the blog (Halnon, 11/4).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.